The battle against the most dangerous type of skin cancer has made a huge leap forward, and it could dramatically change the ...

Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

In recent days, Moderna and Merck reported five-year Phase 2b data showing that their personalized mRNA melanoma vaccine ...

RNA technology, which expedited COVID-19 vaccines, is showing promise against formidable cancers like melanoma and pancreatic ...

Lynch syndrome is an inherited condition affecting 1 in 300 people that causes lifetime cancer risk of up to 80%[1]The ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

Oxford and Moderna’s preventive mRNA cancer vaccine enters trials, targeting high-risk Lynch syndrome patients to train ...

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...